학술논문

The glutaminase inhibitor CB-839 targets metabolic dependencies of JAK2-mutant hematopoiesis in MPN
Document Type
Article
Source
In Blood Advances 14 May 2024 8(9):2312-2325
Subject
Myeloid Neoplasia
Red Cells, Iron, and Erythropoiesis
Hematopoiesis and Stem Cells
Language
ISSN
2473-9529